Tubercuosis incidence and predictors among HIV patients enrolled to tuberculosis preventive therapy in ADAMA town Oromia, Ethiopia
Year: 2026
Type: article
Study design: Observational Study
Abstract: Among opportunistic infections, TB/HIV co-infection affects patients’ quality of life leading to poor physical health and mental disorders compared to HIV infected individuals. Tuberculosis preventive therapy is a relatively new intervention used to prevent the TB infection. Little is known about the TB incidence and its predictors in the current study setting. To determine Tuberculosis incidence and its predictors among HIV patients enrolled to TB preventive therapy in public and private health facilities of Adama town 2023. A Retrospective Cohort study was conducted in Adama town, in selected public and private health facilities providing Antiretroviral Therapy service from March 15, to April 30, 2023. A sample size of 308 study subjects was selected from routinely registered HIV patients on ART from Jan 1 2018 to December 31, 2019. Data extraction checklist developed from the format of WHO standardized forms used by the ART clinics. Data was entered to Epi-info version 7, analyzed by SPSS V-26 using bivariate and multivariable Cox regression proportional hazard model. Variables at 0.25 significant levels in the univariate analysis were included in the final multivariate analysis. Hazard ratio with its 95% confidence interval was used to report the strength of association and statistical significance was declared at p-value < 0.05. A total of 308 patients who completed TB preventive therapy were followed and produced 972.6 person-years of observation, and 11 new TB cases observed during the follow up period. The overall incidence density of TB was 1.13 per 100 person years (95% CI 0.62–2.03). Baseline BMI ≥ 18.5 (AHR = 0.10 95% CI 0.01–0.982), WHO clinical stage III/ or IV (AHR = 11.39 95% CI 1.27–101.9), baseline CD4 cell count ≥ 200 (AHR = 0.12 95% CI 0.02-0 0.79), good TPT adherence (AHR = 0.14 95% Ci 0.02–0.8) and good ARV drugs adherence % (AHR = 0.10,95% CI 0.01–0.72) were significant predictors of TB having of p-value < 0.05 in multivariate cox proportional hazard regression analysis. Even though TB preventive therapy is the most protective factor of active TB occurrence in HIV patients, still baseline BMI < 18.5, WHO clinical stage III and IV, low CD4 count ≥ 200 cell/ul), poor adherence to TPT, and ARV drugs were found to be independent predictors of increased incidence of TB in HIV patients completed TPT. Not applicable.
Source: BMC Infectious Diseases
Institutions: Dilla University, Adama Hospital Medical College
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,090
OpenAlex ID: W7226033276
